Table of Contents Author Guidelines Submit a Manuscript
Tuberculosis Research and Treatment
Volume 2017 (2017), Article ID 3816432, 9 pages
https://doi.org/10.1155/2017/3816432
Research Article

Tuberculosis Test Usage and Medical Expenditures from Outpatient Insurance Claims Data, 2013

Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, GA, USA

Correspondence should be addressed to Kwame Owusu-Edusei Jr.

Received 14 April 2017; Revised 29 June 2017; Accepted 1 August 2017; Published 23 October 2017

Academic Editor: David C. Perlman

Copyright © 2017 US Federal Government. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Centers for Disease Control and Prevention, “Reported Tuberculosis in the United States 2014,” Atlanta, Ga, U.S.A Department of Health and Human Services, 2015.
  2. V. Balaban, S. M. Marks, S. C. Etkind et al., “Tuberculosis elimination efforts in the United States in the era of insurance expansion and the affordable care act,” Public Health Reports, vol. 130, no. 4, pp. 349–354, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. Truven Health Analytics Inc, “Marketscan Research Database: User Guide and Database Dictionary. Ann Arbor, MI,” 2013.
  4. J. C. Smith and C. Medalia, “Health insurance coverage in the United States,” Census Bureau P60-250, 2014, Washington, DC: Current Population Reports. View at Google Scholar
  5. American Medical Association, “CPT Code/Relative Value Search Chicago, IL: American Medical Association,” 2015, https://ocm.ama-assn.org/OCM/CPTRelativeValueSearch.do?submitbutton=accept.
  6. Centers for Medicare & Medicaid Services, “Clinical Diagnostic Laboratory Fee Schedule 2013,” 2014, https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/PhysicianFeeSched/index.html?redirect=/physicianFeeSched.
  7. Centers for Disease Control and Prevention, “Fact Sheets: Interferon-Gamma Release Assays (IGRAs) - Blood Tests for TB Infection Atlanta, GA,” Centers for Disease Control and Prevention, 2012, http://www.cdc.gov/tb/publications/factsheets/testing/igra.htm.
  8. K. Owusu-Edusei, E. W. Flagg, and T. L. Gift, “Hospitalization cost per case of neonatal herpes simplex virus infection from claims data,” Journal of Pediatric Nursing, vol. 30, no. 2, pp. 346–352, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Owusu-Edusei, C. E. Introcaso, and H. W. Chesson, “Hospitalization cost of congenital syphilis diagnosis from insurance claims data in the United States,” Sexually Transmitted Diseases, vol. 40, no. 3, pp. 226–229, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. S. S. Shrestha, P. Zhang, L. Barker, and G. Imperatore, “Medical expenditures associated with diabetes acute complications in privately insured U.S. youth,” Diabetes Care, vol. 33, no. 12, pp. 2617–2622, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. S. Shrestha, P. Zhang, A. Albright, and G. Imperatore, “Medical expenditures associated with diabetes among privately insured U.S. youth in 2007,” Diabetes Care, vol. 34, no. 5, pp. 1097–1101, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Owusu-Edusei, S. M. Marks, R. Miramontes, E. L. Stockbridge, and C. A. Winston, “Tuberculosis hospitalization expenditures per patient from private health insurance claims data, 2010–2014,” International Journal of Tuberculosis and Lung Disease, vol. 21, no. 4, pp. 398–404, 2017. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Kennedy, A Guide to Econometrics, Blackwell Publishing, Malden, Massachussets, 6 edition, 2008.
  14. A. Pooran, H. Booth, R. F. Miller et al., “Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis,” BMC Pulmonary Medicine, vol. 10, article no. 7, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. C. R. Horsburgh Jr., “Priorities for the treatment of latent tuberculosis infection in the United States,” New England Journal of Medicine, vol. 350, no. 20, pp. 2060–2115, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. Centers for Disease Control and Prevention, “Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society,” MMWR Recomm Rep. 2000;49(RR-6):1–51, American Thoracic Society, 2000. View at Google Scholar
  17. Institute of medicine, Ending Neglect: The Elimination of Tuberculosis in the United States, Institute of Medicine, Washington DC, USA, 2000. View at Publisher · View at Google Scholar
  18. Centers for Disease Control and Prevention, “Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection: United States,” MMWR Recomm Rep. 2010;59(RR-5):1–26, 2010. View at Google Scholar
  19. R. Diel, N. Lampenius, and A. Nienhaus, “Cost effectiveness of preventive treatment for tuberculosis in special high-risk populations,” PharmacoEconomics, vol. 33, no. 8, pp. 783–809, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Skinner, “Guide to thoracic imaging,” Australian Family Physician, vol. 44, no. 8, pp. 558–562, 2015. View at Google Scholar · View at Scopus
  21. United States Census Bureau, “Annual Estimates of the Resident Population for Selected Age Groups by Sex for the United States, States, Counties, and Puerto Rico Commonwealth and Municipios,” 2014, https://factfinder.census.gov/faces/tableservices/jsf/pages/productview.xhtml?src=bkmk.
  22. LG. Hansen and S. Chang, Health research data for the real world: the MarketScan databases, Truven Health Analytics, 2011, White Paper.
  23. T. Henderson, J. Shepheard, and V. Sundararajan, “Quality of diagnosis and procedure coding in ICD-10 administrative data,” Medical Care, vol. 44, no. 11, pp. 1011–1019, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. J. W. Peabody, J. Luck, S. Jain, D. Bertenthal, and P. Glassman, “Assessing the accuracy of administrative data in health information systems,” Medical Care, vol. 42, no. 11, pp. 1066–1072, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Trivedi, S. Saksena, and R. K. Gupta, “Magnetic resonance imaging in central nervous system tuberculosis,” Indian Journal of Radiology and Imaging, vol. 19, no. 4, pp. 256–265, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Owusu-Edusei, E. L. Stockbridge, C. A. Winston, M. Kolasa, and R. Miramontes, “Tuberculin skin test and interferon-gamma release assay use among privately insured persons in the United States,” The International Journal of Tuberculosis and Lung Disease, vol. 21, no. 6, pp. 684–689, 2017. View at Publisher · View at Google Scholar